← Back to All Filings

INSMED Director Files Intent to Sell $1.94M in Company Stock

Low SignificanceNovember 13, 2025 at 1:02:25 PM EST

INSMED Inc

$INSM144CIK: 0001104506

Subscribe to track INSM

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

INSMED Director Files Intent to Sell $1.94M in Company Stock

Company: INSMED Inc (INSM) Form: 144 | Filed: 2025-11-13 Significance: Low

Insider: ANDERSON ELIZABETH M Title: Director | Relationship: Director

Transaction: • Type: Proposed Sale • Shares: 10,000 • Price: ~$194.00 • Value: $1,940,000 • Owned After: Not Disclosed

Key Insight: A director has filed a notice of proposed sale for 10,000 shares. The transaction is of low significance, representing a negligible fraction of the company's market capitalization and the insider's potential holdings.

Market Context: The sale constitutes just 0.0047% of the company's $40.93B market cap and 0.0047% of its outstanding shares, making it an immaterial event for a company of this size.

Comprehensive Analysis

SEC Filing Analysis: INSMED Inc (INSM)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An INSMED Inc. director has filed a notice of intent to sell 10,000 shares of common stock, valued at approximately $1.94 million.
  • Market Impact: The transaction is considered immaterial given its small size relative to INSMED's $40.93 billion market capitalization and is unlikely to influence the stock.

Company Information

FieldValue
CompanyINSMED Inc
Ticker SymbolINSM
CIK0001104506
IndustryPharmaceutical Preparations

Insider Information

FieldValue
NameANDERSON ELIZABETH M
CIK0001758247
Title/PositionDirector
RelationshipDirector

Transaction Details

FieldValue
Form Type144
Transaction Date2025-11-13 (Approximate)
Transaction CodeS (Proposed Sale)
Security TypeCommon Stock
Shares Involved10,000
Price Per Share$194.00
Total Value$1,940,000
Shares Owned AfterNot Disclosed
Ownership TypeNot Disclosed

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$1,940,000
% of Market Cap0.0047%
Shares Transacted10,000
% of Shares Outstanding0.0047%
Post-Transaction OwnershipNot Disclosed
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a large-cap company with a market capitalization of $40.93 billion, a transaction of $1.94 million is considered routine and financially insignificant.
  • Ownership Concentration: Without post-transaction ownership data, a full assessment is not possible, but the sale itself is a very small fraction of the total shares outstanding.
  • Transaction Significance: The sale represents less than 0.01% of both the market cap and shares outstanding, placing it firmly in the 'Low' significance category. Such sales are common for liquidity, tax planning, or diversification and do not typically signal a change in the insider's outlook on the company.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction size is too small to be considered a meaningful signal or to have a tangible impact on trading dynamics for a stock of this size.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction size is a minor fraction of the typical daily trading volume.
  • Sentiment Indicator: Neutral. The market is unlikely to react to a sale of this size from a non-executive director.

Additional Context

Transaction Notes

  • This Form 144 filing is a notice of a proposed sale, not a confirmation that the sale has been executed.
  • The shares intended for sale were originally acquired via stock awards in 2019 and 2020 as part of compensation.
Topics:#SECFiling#InsiderTrading#INSM#Insmed#Form144#InsiderSell#StockMarket#Investing#Biotech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.